Sun 16 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| # | Title | Date | Type of news | Link of news |
|---|---|---|---|---|
| 80 | Safety Signal of Hypokalemia associated with the use of Ceftriaxone | Signal | ||
| 79 | Safety Signal of Molluscum Contagiosum associated with the use of Fingolimod | Signal | ||
| 78 | Safety Signal of Rhabdomyolysis associated with the use of Pembrolizumab | Signal | ||
| 75 | Safety Signal of Skin Cancer associated with the use of Methotrexate | Signal | ||
| 81 | Baricitinib (Olumiant®) and increased risk of diverticulitis: Recommendations for Healthcare Professionals from the SFDA | Precautions | ||
| 76 | Safety Signal of Cardiac Failure associated with the use of Ibrutinib | Signal | ||
| 74 | Switching between Warfarin Brands and The Importance of Close Monitoring of INR | Precautions | ||
| 73 | Hydroxychloroquine and Chloroquine Alone and in Combination with Azithromycin and Potential Increased Risk of Heart Rhythm Problems | Warning | ||
| 72 | SFDA Recommendations for Healthcare Professionals Regarding The Unapproved Use of Hydroxychloroquine and Chloroquine in Treatment of COVID-19 | Warning | ||
| 71 | SFDA Advises Continued Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs) in Patients with COVID-19 | Precautions |
Last update date: 13/08/2026 at 10:30 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.